Page 12 - வெளிப்படுகிறது தொழில்நுட்பங்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Caisson Biotech and Heparinex Announce Positive Exam Report of European Patent

AUSTIN, Texas /Massachusetts Newswire – National News/ Caisson Biotech and parent company Heparinex are pleased to announce that they have received a positive examination report from the European Patent Office for a patent covering the chemoenzymatic production of heparosan utilized in the HEPtune® drug delivery platform. Once certified, the new patent family will increase patent coverage across Europe, adding to the U.S. holdings. The HEPtune platform, which utilizes heparosan, a naturally occurring polysaccharide, has been validated as a novel half-life extension and drug delivery alternative to commonly used polyethylene glycol (PEG). Unlike PEG, heparosan is naturally found in humans, is completely biodegradable, and will not trigger anaphylactic shock or anti-drug antibodies. The HEPtune platform has been applied to numerous drug classes including biologics, and small molecules via nanocarriers, including liposomes.

United statesPaul deangelisEmergent technologies incCaisson biotechEuropean patent officeUniversity of oklahoma health sciences centerNational newsStanford universityUniversity of oklahoma professor drMassachusetts newswirePresidential professorOklahoma health sciences centerChief scientistOklahoma professorEmergent technologiesஒன்றுபட்டது மாநிலங்களில்

MSU Researchers Exploring Cement Alternative Using Fungi, Bacteria

MSU Researchers Exploring Cement Alternative Using Fungi, Bacteria
ypradio.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ypradio.org Daily Mail and Mail on Sunday newspapers.

United statesMontana state universityChelsea heveranRobin gerlachErica espinosa ortizSadie phillipsResearchers at montana state universityResearch professor erica espinosa ortizNational science foundationBiofilm engineeringAssistant research professor erica espinosa ortizRachel cramerEngineering professor chelsea heveranArda akyelBiological engineering professor robin gerlachAssociate professor

Pure Transplant Solutions and King s College London to Support NHS Funded GAMECHANgER-1 Clinical Trial

(AUSTIN, Texas) NEWS: Pure Transplant Solutions, LLC (PTS), a collaboration driven biotechnology company focused on the development of human leukocyte antigen (HLA)-based diagnostics and therapeutics within the field of transplantation, is proud to announce that it has entered into a collaboration agreement with King’s College London, a leading university providing world-class teaching and cutting-edge research, to support the Phase IIa GAMECHANgER-1 clinical trial. The trial aims to determine whether adoptive transfer of regulatory T cells (Tregs) into HLA sensitised patients can suppress memory T and B cell responses against specific HLA antigens in order to extend the longevity of donor organs.

United kingdomUnited statesCity ofAnthony dorlingResearch excellence frameworkEmergent technologies incKing college londonPure proteinPure transplant solutionsUniversity of oklahomaQs world university rankingsCentre for nephrologyCollege londonTransplant inflammationHonorary consultant nephrologistRico buchli

Pure Transplant Solutions Announces Collaboration with King s College London to Support NHS Funded GAMECHANgER-1 Clinical Trial for HLA Sensitized Patients with End Stage Renal Disease

Pure Transplant Solutions Announces Collaboration with King s College London to Support NHS Funded GAMECHANgER-1 Clinical Trial for HLA Sensitized Patients with End Stage Renal Disease
californianewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from californianewswire.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesCity ofAnthony dorlingResearch excellence frameworkEmergent technologies incKing college londonPure proteinPure transplant solutionsUniversity of oklahomaQs world university rankingsCentre for nephrologyCollege londonTransplant inflammationHonorary consultant nephrologistRico buchli

Pure Transplant Solutions Announces Collaboration with King s College London to Support NHS Funded GAMECHANgER-1 Clinical Trial for HLA Sensitized Patients with End Stage Renal Disease

Pure Transplant Solutions Announces Collaboration with King s College London to Support NHS Funded GAMECHANgER-1 Clinical Trial for HLA Sensitized Patients with End Stage Renal Disease
floridanewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from floridanewswire.com Daily Mail and Mail on Sunday newspapers.